With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus||Research Institute at Nationwide Children's Hospital / Kevin Cassady, MD & Christopher Walker, PhD||Innovation Grants||2016||Ohio|
|Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies||Baylor College of Medicine / Stephen Mack, PhD||Young Investigator Grants||2016||Texas|
|Investigating Racial Disparities in Pediatric Acute Leukemia||University of California San Francisco / Lena Winestone, MD||Young Investigator Grants||2016||California|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|Micro-environmental Regulators of Ewing sarcoma Metastasis||University of Pittsburgh / Kelly Bailey, MD/PhD||Young Investigator Grants||2016||Pennsylvania|
|Modeling Pediatric Spinal Gliomas Using Murine Spinal Neural Stem Cells||The Johns Hopkins University School of Medicine / Charles Eberhart, MD/PhD & Eric Raabe MD/PhD||Innovation Grants||2016||Maryland|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children’s Hospital / Leonard Zon, MD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors||Vanderbilt University Medical Center / William Tansey, PhD||Innovation Grants||2016||Tennessee|
|Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome||St. Jude Children’s Research Hospital / Lisa Jacola, PhD||Psychosocial Grants||2016||Tennessee|